Mebeverine



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Sinus Disorder 30.8%
Drug Use For Unknown Indication 10.0%
Poisoning Deliberate 7.7%
Diabetes Mellitus 6.2%
Headache 6.2%
Product Used For Unknown Indication 6.2%
Irritable Bowel Syndrome 5.4%
Asthma 3.8%
Diarrhoea 3.8%
Epilepsy 3.1%
Muscle Spasms 3.1%
Constipation 2.3%
Migraine 2.3%
Depression 1.5%
Fibromyalgia 1.5%
Hypertension 1.5%
Hypothyroidism 1.5%
Prophylaxis 1.5%
Bowel Spasm 0.8%
Lower Respiratory Tract Infection 0.8%
Renal Failure Chronic 16.7%
Death 8.3%
Gamma-glutamyltransferase Increased 8.3%
Multiple Drug Overdose 8.3%
Upper Gastrointestinal Haemorrhage 8.3%
Vision Blurred 8.3%
Angioedema 4.2%
Depressed Level Of Consciousness 4.2%
Henoch-schonlein Purpura 4.2%
Major Depression 4.2%
Middle Insomnia 4.2%
Multiple Drug Overdose Intentional 4.2%
Poisoning Deliberate 4.2%
Porphyria 4.2%
Umbilical Hernia Repair 4.2%
Vomiting 4.2%
Concomitant
Product Used For Unknown Indication 45.5%
Drug Use For Unknown Indication 8.8%
Crohn's Disease 7.2%
Rheumatoid Arthritis 5.5%
Irritable Bowel Syndrome 4.4%
Hypertension 4.1%
Pain 3.5%
Depression 2.5%
Type 2 Diabetes Mellitus 2.4%
Polyuria 2.1%
Colorectal Cancer Metastatic 1.9%
Blood Pressure 1.6%
Fibromyalgia 1.6%
Asthma 1.5%
Colitis Ulcerative 1.4%
Migraine 1.3%
Prophylaxis 1.3%
Post-traumatic Stress Disorder 1.2%
Analgesic Therapy 1.1%
Ill-defined Disorder 1.0%
Vomiting 8.8%
Liver Function Test Abnormal 8.2%
Swollen Tongue 8.2%
Renal Failure Acute 6.9%
Reversible Posterior Leukoencephalopathy Syndrome 6.3%
Weight Decreased 6.3%
Tremor 5.7%
Dizziness 5.0%
Left Ventricular Dysfunction 5.0%
Vision Blurred 4.4%
Visual Impairment 4.4%
Hypoaesthesia 3.8%
Pancreatitis Acute 3.8%
Rhabdomyolysis 3.8%
White Blood Cell Count Increased 3.8%
Blood Pressure Increased 3.1%
Dyspnoea 3.1%
Headache 3.1%
Hyperprolactinaemia 3.1%
Jaundice 3.1%